AB-BIOTICS SA
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Holding, Subsidiary
- Established
- 2004-01-01
- Employees
- 33
- Market Cap
- -
- Website
- http://www.ab-biotics.com
Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management
Not Applicable
Completed
- Conditions
- Non Alcoholic Fatty Liver
- Interventions
- Other: PlaceboDietary Supplement: Probiotic composition
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2022-02-24
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 100
- Registration Number
- NCT04823676
- Locations
- 🇲🇽
Hospital General Dr. Manuel Gea Gonzalez, Mexico city, Mexico
Combination of AB-LIFE Probiotic Plus Monacolin K to Reduce Blood Cholesterol
Not Applicable
Completed
- Conditions
- Hypercholesterolemia
- Interventions
- Dietary Supplement: AB-LIFE with Monacolin KOther: Placebo
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 40
- Registration Number
- NCT04677335
Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19
Not Applicable
Completed
- Conditions
- SARS-CoV Infection
- Interventions
- Other: PlaceboDietary Supplement: Probiotics
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 300
- Registration Number
- NCT04517422
- Locations
- 🇲🇽
Hospital General Dr. Manuel Gea Gonzalez, Mexico city, Mexico
Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota
Not Applicable
Completed
- Conditions
- Vaginal Infection
- Interventions
- Dietary Supplement: Lactobacillus plantarum
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2020-07-08
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 30
- Registration Number
- NCT04461782
- Locations
- 🇪🇸
Sta MarÃa del Rosell university hospital, Cartagena, Spain
Effect of a Probiotic Formula on Reducing SIBO in IBS Patients
Not Applicable
Terminated
- Conditions
- Irritable Bowel SyndromeSmall Intestinal Bacterial Overgrowth
- Interventions
- Dietary Supplement: Probiotic
- First Posted Date
- 2020-03-20
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 8
- Registration Number
- NCT04316806
- Locations
- 🇪🇸
Dr. Bofill Clinic, Girona, Spain
Probiotic Intervention After Surgical Removal of Mandibular Third Molars
Not Applicable
Completed
- Conditions
- Surgery--ComplicationsMolar, Third
- Interventions
- Dietary Supplement: Probiotic AB-DENTALACOther: PlaceboProcedure: Surgical removal of mandibular third molars at baseline
- First Posted Date
- 2019-12-18
- Last Posted Date
- 2020-05-06
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 38
- Registration Number
- NCT04203771
- Locations
- 🇪🇸
Hospital de Nens de Barcelona (Children's Hospital of Barcelona)), Barcelona, Spain
Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic
Not Applicable
Completed
- Conditions
- HIVPremature Aging
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: ProbioticDietary Supplement: Prebiotic
- First Posted Date
- 2018-05-31
- Last Posted Date
- 2020-07-08
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 89
- Registration Number
- NCT03542786
- Locations
- 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Study of Colonization of Strains L.Plantarum and L.Brevis in the Product AB-DENTALAC Chewing Gum
Not Applicable
Completed
- Conditions
- Periodontal Disease
- Interventions
- Dietary Supplement: AB-DENTALAC [Probiotics (study)]Dietary Supplement: Placebo (control)
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 40
- Registration Number
- NCT03540498
Streptococcus Dentisani Colonization Capacity in a Split Mouth Model
Not Applicable
Completed
- Conditions
- Oral Health
- Interventions
- Other: Streptococcus dentisani CECT7746
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 11
- Registration Number
- NCT03522363
- Locations
- 🇪🇸
Lluis Alcanyis Foundation dental clinic, University of Valencia, Valencia, Spain
Study to Evaluate the Clinical Efficacy of Streptococcus Dentisani CECT 7746 in Caries Risk Reduction
Phase 1
Completed
- Conditions
- Caries
- Interventions
- Biological: PlaceboBiological: Probiotic
- First Posted Date
- 2018-03-19
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- AB Biotics, SA
- Target Recruit Count
- 76
- Registration Number
- NCT03468842
- Locations
- 🇪🇸
Lluis Alcanyis Foundation dental clinic, University of Valencia, Valencia, Spain
© Copyright 2025. All Rights Reserved by MedPath